HAEMONETICS CORP — Director's Dealing 2019

Feb 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2019-02-15

Reporting Person: GELBMAN RONALD G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-15	Common Stock	M	8196	$36.37	Acquired	61258	Direct
2019-02-15	Common Stock	S	8196	$86.52	Disposed	53062	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-15	Non-qualified Stock Option (Right to Buy)	$36.37	M	8196	Disposed	2019-07-27	Common Stock (8196)	Direct

Footnotes

F1: This number includes unvested restricted stock units previously reported.

F2: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.